{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:49:34Z","timestamp":1773665374610,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the past decade, rituximab in combination with polychemotherapy has become the standard approach in most patients with advanced CD20\u2010positive B\u2010cell lymphoma. In mantle cell lymphoma (MCL), follicular lymphoma and diffuse large B\u2010cell lymphoma, rituximab has been used as monotherapy and in combination with various chemotherapy regimens in different treatment situations. Routinely, rituximab is given intravenously, but other routes of administration have also been described. Here, we report a 64\u2010yr\u2010old woman who was previously treated with three different chemotherapy regimens for stage IV MCL. No sustained clinical and radiological response could be achieved. The patient\u2019s general status declined and she developed massive ascites as the dominant clinical problem. Local, intraperitoneal administration of rituximab was initiated as an experimental treatment approach. After 11 doses of rituximab, the general status of the patient improved significantly, ascites resolved completely and computed tomography (CT) scans demonstrated a partial remission of intra\u2010abdominal lymph nodes and splenomegaly. Furthermore, we observed a regression of mediastinal lymph nodes, pleural effusion and centrocytes in peripheral blood as well as improvement of anaemia. The response to the experimental treatment has maintained for more than 6\u2003months. In summary, we observed a sustained local and systemic response to intraperitoneal administration of rituximab in a patient with heavily pretreated advanced MCL.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2007.00955.x","type":"journal-article","created":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T08:09:10Z","timestamp":1191053350000},"page":"546-549","source":"Crossref","is-referenced-by-count":11,"title":["Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response"],"prefix":"10.1111","volume":"79","author":[{"given":"Martina","family":"Crysandt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Engelbertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Galm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainhardt","family":"Osieka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,28]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2188"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk152"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.6.8.1175"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.s.002"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.30156"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008416911099"},{"key":"e_1_2_4_9_2","first-page":"465","article-title":"Radiation dosimetry results and safety correlations from 90Y\u2010ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non\u2010Hodgkin\u2019s lymphoma: combined data from 4 clinical trials","volume":"44","author":"Wiseman GA","year":"2003","journal-title":"J Nucl Med"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.3470"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1636"},{"key":"e_1_2_4_12_2","first-page":"753","article-title":"Intraventricular treatment of relapsed central nervous system lymphoma with the anti\u2010CD20 antibody rituximab","volume":"89","author":"Schulz H","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07523.x"},{"key":"e_1_2_4_14_2","first-page":"ECR39","article-title":"Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL","volume":"89","author":"Schmidt HH","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0479-y"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.09.018"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.74.887.740983"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.05.007"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2007.00955.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2007.00955.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T01:09:26Z","timestamp":1697072966000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2007.00955.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,28]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1600-0609.2007.00955.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00955.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,28]]}}}